Spasticity Drugs Market will Reach US$ 2.89 Billion by 2034
The Spasticity Drugs Market is experiencing significant growth due to the rising prevalence of neurological disorders, increasing awareness of muscle spasticity treatment, and ongoing advances in pharmaceutical therapies. Spasticity is a common symptom associated with conditions such as multiple sclerosis, … Read more